Source: http://www.readbag.com/accessdata-fda-cdrh-docs-pdf8-k081331
Timestamp: 2020-05-27 10:40:02
Document Index: 447894628

Matched Legal Cases: ['arts 800', 'art 807', 'art 801', 'art 820', 'art 801', 'art 807', 'art 21']

Read K081331.pdf
Read K081331.pdf text version
3O)l33I1 (F,9
I 0~)JUL
510(k) Summary for the Spineworks FixxSure Cross Link
In accordance with 21 CFR 807.92 of the Federal Code of Regulations the following 510(k) summary is submitted for the SpineWorks FixxSure Cross Link. Date Prepared: May 7, 2008 1. Submitter: SpineWorks LLC 16742 Gothard St. Suite 101 Huntington Beach, CA 92647 Contact Person: J.D. Webb The OrthoMedix Group, Inc. 1001 Oakwood Blvd Round Rock, TX 78681 Telephone: 512-388-0199
2. Trade name: Common Name: Classification Name:
FixxSure Cross Link pedicle screw system crosslink Pedicle screw spinal system Class II 21 CFR 888.3070 MNI/MNH
3. Predicate or legally marketed devices which are substantially equivalent: Sea Spine Crossbar (K032739) Acme/Talon Pedicle Screw system (K071824). 4. Description of the device: The SpineWorks FixxSure Cross Link allows spinal surgeons to convert a dual-rod construct into a frame and increase overall construct strength. The FixxSure Cross Link comes in a multi-span and fixed design, both of which can be rigidly locked onto a dual-rod construct and has the capability of being manipulated into various planes of angulation. The SpineWorks implant has a proprietary dual locking mechanism allowing maximum Cross Link/rod connection while offering superior ease of insertion/use. Materials: The components in this submission are fabricated from Ti6AI4V alloy, conforming to ASTM F136, which is known to have good biocompatibility. Function: Cross Link systems were introduced to increase the rigidity of the pedlicle screw constructs. 5. Intended Use: The SpineWorks FixxSure Cross Link is intended work with the Talon Pedicle Screw system to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of thoracic, lumbar, and sacral spine: severe spondylolisthesis (grades 3 and 4) of the L5-S1 vertebra; degenerative spondylolisthesis with objective evidence of neurologic impairment; fracture; dislocation; scoliosis; kyphosis; spinal tumor; and failed previous fusion (pseudarthrosis). The SpineWorks FixxSure Cross Link must be used with the Talon Pedicle Screw system. iv
Comparison of the technological characteristics of the device to predicate and legally marketed devices: The FixxSure Cross Link is similar to the predicate device in terms of material, design and indications.
7. Summary of Nonclincal Tests Testing was conducted according to ASTM F1717 and F1798 with adequate strength.
SpineWorks, LLC.
% OrthoMedix Group, Inc.
Mr. J.D. Webb 1001 Oakwood Boulevard Round Rock, TX 78681 Dear Mr. Webb: Re:
JUL 2 3 2O0B
K081331 Trade/Device Name: FixxSure Cross Link Regulation Number: 21 CFR 888.3070 Regulation Name: Pedicle screw spinal system Regulatory Class: Class II Product Code: MNH, MNI Dated: May 7, 2008 Received: May 12, 2008
Dear Mr. Webb: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Page 2 - Mr. J.D. Webb
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, &quot;Misbranding by reference to premarket notification&quot; (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (240) 276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at (240) 276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at toll-free number (800) 638-2041 or (240) 276-3150 or the Internet address http://www.fda.gov/cdrh/industry/support/index.html. Sincerely yours,
510(k) Number (if known): Device Name: Indications for Use: The SpineWorks FixxSure Cross Link is intended work with the Talon Pedicle Screw system to provide immobilization and stabilization of spinal segments in skeletally mature patients as an adjunct to fusion in the treatment of the following acute and chronic instabilities or deformities of thoracic, lumbar, and sacral spine: severe spondylolisthesis (grades 3 and 4) of the L5-S1 vertebra; degenerative spondylolisthesis with objective evidence of neurologic impairment; fracture; dislocation; scoliosis; kyphosis; spinal tumor; and failed previous fusion (pseudarthrosis). The SpineWorks FixxSure Cross Link must be used with the Talon Pedicle Screw system. O i 3
SpineWorks FixxSure Cross Link
Prescription Use X (Part 21 CFR 801 Subpart D)
(Divisio Sign-Off Division of General, Restorative, and Neurological Devices 510(k)Number
Lt&amp;Q4 i